Talking Biotech with Dr. Kevin Folta New Therapeutics for Novel Problems through Collaboration - Dr. Betsy O'neill
Oct 8, 2022
Chapters
Transcript
Episode notes
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18
Introduction
00:00 • 2min
Horizon Therapeutics VP of External Innovation
02:00 • 2min
Is There a Difference Between Autoimmune and Fibrosis?
03:52 • 3min
Horizon's Vice President of External Innovation
07:03 • 2min
Collaborations in the Academic Setting?
09:03 • 3min
Calabra's Talking Biotech Podcast
12:07 • 3min
Startup Saturdays - A Twitter Thread to Introduce You to Biotech Startups
14:47 • 2min
What's Your Twitter Feed for Biotech Startups?
16:24 • 2min
The Potential of External Innovation in Biotechnology
18:26 • 3min
The COVID Vaccines and SIRNA Delivery Challenge
21:33 • 2min
Collaborative Partnerships - What Are Some Good Examples?
23:06 • 3min
CoVID Is Over, but I'm Glad It's Over
25:51 • 3min
Immunotherapy - What's in the Pipeline?
29:08 • 1min
DAX Dillamab for CD 40L Diseases
30:34 • 5min
Is There a Balance Between Antibodies and Antibody Therapy?
35:48 • 3min
Multiple Sclerosis, I'm Going to Wind Up in a Wheelchair
38:30 • 2min
Horizon Therapy
40:44 • 5min
Talking BioTech Podcast - What's Next?
45:32 • 2min